文献速递介入泌尿生殖外周血管DSA

前列腺动脉栓塞术:单中心551例手术的经验教训

Prostatic Artery Embolization: Lessons From 551 Procedures at a Single-Center.
PubMed 文献 · Acad Radiol · 2024-06-10

这项单中心回顾性研究分析了2019年1月至2023年7月由经验丰富的介入放射科医生实施的551例前列腺动脉栓塞术,评估其治疗良性前列腺增生的疗效与安全性。术后三个月前列腺体积和PSA显著下降,IPSS和QoL评分明显改善,IIEF评分稳定,仅报告16例轻微并发症,无严重并发症;2019年至2023年间透视时间和手术时间显著缩短。

要点

  • IPSS改善9分、QoL改善2分,IIEF评分保持稳定,仅16例轻微并发症、无严重并发症。
  • 2019年首例至2023年常规开展,透视时间缩短25.2%、手术时间缩短26.1%(p < .0001)。

核心结论

  • 前列腺动脉栓塞术是治疗良性前列腺增生的安全有效方法,可显著改善下尿路症状和生活质量,同时维持性功能。

研究设计与样本

  • 单中心回顾性研究,分析2019年1月至2023年7月由经验丰富的介入放射科医生实施的551例前列腺动脉栓塞术,评估患者人口学特征、手术细节(辐射暴露、颗粒大小)、并发症率及术前术后前列腺体积、PSA、IPSS、QoL和IIEF评分。

诊断标准与关键数值

  • 551例男性平均年龄68.81±8.61岁,均行双侧栓塞,主要使用100-300 µm颗粒(n = 441)。
  • IPSS改善9分、QoL改善2分,IIEF评分保持稳定。
  • 仅报告16例轻微并发症,无严重并发症。
  • 2019年首例与2023年常规开展相比,透视时间缩短25.2%、手术时间缩短26.1%,p < .0001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This retrospective study evaluates the efficacy and safety of Prostatic Artery Embolization (PAE) for the treatment of benign prostatic hyperplasia (BPH) over five years at a single center, conducted by an experienced interventional radiologist.

MATERIALS AND METHODS: We analyzed 551 PAE interventions from January 2019 to July 2023. Key metrics included patient demographics, procedural details (radiation exposure, particle size), complication rates, pre- and post-interventional prostatic volume (PV), Prostate-specific Antigen (PSA) levels, International Prostate Symptom Score (IPSS), Quality of Life (QoL) scores and International Index of Erectile Function (IIEF) scores. We assessed data normality, performed group and paired sample comparisons, and evaluated correlations.

RESULTS: For 551 men, the average patient age was 68.81 ± 8.61 years undergoing bilateral embolization. The particle size predominantly used was 100-300 µm (n = 441). PAE lead to significant (p < .001) reduction of both PV (-9.67 ± 14.52 mL) and PSA level (-2,65 ± 1.56 ng/mL) between pre- and three months after PAE. Substantial improvement were observed for IPSS (-9 points) and QoL scores (-2 points), with stable IIEF scores. Only minor complications (n = 16) were reported, and no major complications were observed. Between the first PAE in 2019 and the routinely performed PAE in 2023 significant (p < .0001) reductions in fluoroscopy (-25.2%), and procedural times (-26.1%) were observed.

CONCLUSION: In conclusion, PAE is a safe and effective treatment for BPH, offering significant improvements in lower urinary tract symptoms (LUTS) and QoL while maintaining sexual function.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Alizadeh LS, Radek D, Booz C, et al. Prostatic Artery Embolization: Lessons From 551 Procedures at a Single-Center. Acad Radiol. 2024. PMID: 38862346. doi:10.1016/j.acra.2024.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。